US Patent Issued to KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY on Nov. 11 for "Pyridinyltriazine derivative having protein kinase inhibitory activity, and pharmaceutical composition for preventing, ameliorating, or treating cancer comprising same" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,812, issued on Nov. 11, was assigned to KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (Seoul, South Korea).

"Pyridinyltriazine derivative having protein kinase inhibitory activity, and pharmaceutical composition for preventing, ameliorating, or treating cancer comprising same" was invented by Tae Bo Sim (Seoul, South Korea), Seong Shick Ryu (Seoul, South Korea), Yun Ju Nam (Seoul, South Korea) and Woo Young Hur (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to: a compound selected from among a novel pyridinyltriazine derivative having protein kinase inhibitory activity, a pharmaceutically acceptable salt...